elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Paclitaxel
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Paclitaxel
RIS
0.002
(Research Intensity Score)
Papers
239
Top papers
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
2022 · 574 citations
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
2022 · 492 citations
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
2025 · 53 citations
Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles
2021 · 467 citations
Carbon Nanotubes: Smart Drug/Gene Delivery Carriers
2021 · 446 citations
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
2020 · 613 citations
Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment
2023 · 81 citations
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
2026 · 16 citations
Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
2020 · 254 citations
Newest papers
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
2026 · 16 citations
Green synthesis and characterization of platinum nanoparticles loaded with paclitaxel and coated with chitosan: a promising approach for breast cancer treatment
2026 · 5 citations
Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles
2026 · 4 citations
A Renally Excretable Gold Nanoparticle Oncology Platform Enabling Effective Photothermal Therapy and Chemotherapy Combination
2026 · 4 citations
Paclitaxel liposome with anti–HER-2 drugs as first-line therapy for recurrent/metastatic HER-2–positive breast cancer: a real-world study
2026
Nanoparticle‐Mediated TIPE1 mRNA Delivery Enhances Paclitaxel Sensitivity in Triple‐Negative Breast Cancer by Modulating RAB7A Ubiquitination‐Associated Stability and Autophagy
2026
Kết quả điều trị Paclitaxel trong ung thư thực quản giai đoạn tiến triển di căn kháng Platinum
2026
Carboplatin/Paclitaxel can be an effective alternative for cisplatin-ineligible patients with locally advanced HNSCC
2026
DNMT3B- SLC25A6 axis-mediated DNA methylation regulates ferroptosis to promote paclitaxel resistance in triple-negative breast cancer
2026
Browse all papers →
Paclitaxel's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Paclitaxel's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link